TTN-AS1 and hepatocellular carcinoma: MiR-139-5p inhibitors counteracted TTN-AS1 knockdown-induced inhibitory effects on SPOCK1 expression, and overexpression of SPOCK1 could counteract TTN-AS1 knockdown-caused inhibiting effects on HCC cell malignant phenotypes.